Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Pacira Pharmaceuticals Inc (NASDAQ:PCRX)

33.50
Delayed Data
As of Oct 20
 +0.40 / +1.21%
Today’s Change
29.95
Today|||52-Week Range
58.95
+3.72%
Year-to-Date

Today’s Trading

Previous close33.10
Today’s open33.45
Day’s range33.15 - 33.90
Volume481,570
Average volume (3 months)664,132
Market cap$1.4B
Dividend yield--
Data as of 3:59pm ET, 10/20/2017

Growth & Valuation

Earnings growth (last year)-2,650.00%
Earnings growth (this year)-130.65%
Earnings growth (next 5 years)+120.00%
Revenue growth (last year)+10.99%
P/E ratioNM
Price/Sales4.35
Price/Book5.73

Competitors

 Today’s
change
Today’s
% change
EBSEmergent BioSolution...+0.28+0.69%
INVAInnoviva Inc-0.27-1.91%
LXRXLexicon Pharmaceutic...-0.18-1.59%
IPXLImpax Laboratories I...+0.25+1.19%
Data as of 4:02pm ET, 10/20/2017

Financials

Next reporting dateNovember 2, 2017
EPS forecast (this quarter)-$0.02
Annual revenue (last year)$276.4M
Annual profit (last year)-$37.9M
Net profit margin-13.73%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
Chairman &
Chief Executive Officer
David M. Stack
Chief Financial Officer
Charles A. Reinhart
Corporate headquarters
Parsippany, New Jersey

Forecasts